2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

Smith, I (author)

Procter, M (author)

D Gelber, R (author)

show more...

Guillaume, S (author)

Feyereislova, A (author)

Dowsett, M (author)

Goldhirsch, A (author)

Untch, M (author)

Mariani, G (author)

Baselga, J (author)

Kaufmann, M (author)

Cameron, D (author)

Bell, R (author)

Bergh, J (author)

Karolinska Institutet

Coleman, R (author)

Wardley, A (author)

Harbeck, N (author)

Lopez, RI (author)

Mallmann, P (author)

Gelmon, K (author)

Wilcken, N (author)

Wist, E (author)

Rovira, PS (author)

Piccart-Gebhart, M (author)

show less...

 (creator_code:org_t)

2007

2007

English.

In: Lancet (London, England). - 1474-547X. ; 369:9555, s. 29-36

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)